Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-07ALNY3ALNYLAM PHARMACEUTICALS, INC. - Form 3 FilingMEDIUM
This filing details the initial ownership of securities by Melissa McLaughlin, Chief Human Resources Officer of ALNYLAM PHARMACEUTICALS, INC. As of March 25, 2026, McLaughlin directly holds 13,353 shares of common stock. This includes 11,730 shares from restricted stock units (RSUs) granted on April 1, 2025, and 1,623 ...
Mega CapBiotechnology
2026-04-07IMMP3IMMUTEP Director Peter Meyers Reports 4.05M Shares and Performance Rights Holdings
This SEC Form 3 filing reports the initial statement of beneficial ownership by Peter Andrew Meyers, a director of IMMUTEP Ltd. The filing discloses Meyers' holdings of 4,052,173 ordinary shares in the company. Additionally, the filing reveals four separate grants of performance rights (rights to receive ordinary share...
Nano CapBiotechnology
2026-04-07PPBT3Ownership Filing for Purple Biotech Ltd.MEDIUM
This filing details the ownership of Suzana Zilberberg in Purple Biotech Ltd. (PPBT). Ms. Zilberberg holds 3,062,500 ordinary shares, which includes 2,454,167 unvested restricted stock units (RSUs). Additionally, she holds stock options to purchase 112,500 ordinary shares, fully vested and exercisable, expiring on Dece...
Nano CapBiotechnology